These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 8287388
21. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study. Sadowski Z, Szwed H, Kuch-Wocial A, Kubasik A, Januszewicz W, Krupa-Wojciechowska B, Polak G, Stejfa M, Dvorak I, Balazovjech I, Dubai G, Simon K. J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912 [Abstract] [Full Text] [Related]
23. Longitudinal mitral annulus velocities are reduced in hypertensive subjects with or without left ventricle hypertrophy. Borges MC, Colombo RC, Gonçalves JG, Ferreira Jde O, Franchini KG. Hypertension; 2006 May; 47(5):854-60. PubMed ID: 16585417 [Abstract] [Full Text] [Related]
31. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients]. Ito O, Okamoto M, Murakami Y, Nakayama R. J Cardiol; 1991 Nov; 21(4):931-41. PubMed ID: 1844449 [Abstract] [Full Text] [Related]
36. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. Wachtell K, Papademetriou V, Smith G, Gerdts E, Dahlöf B, Engblom E, Aurigemma GP, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Am Heart J; 2004 Sep; 148(3):538-44. PubMed ID: 15389245 [Abstract] [Full Text] [Related]
37. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Devereux RB, Dahlof B, Levy D, Pfeffer MA. Am J Cardiol; 1996 Jul 01; 78(1):61-5. PubMed ID: 8712120 [Abstract] [Full Text] [Related]
38. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study. Wachtell K, Palmieri V, Olsen MH, Gerdts E, Papademetriou V, Nieminen MS, Smith G, Dahlöf B, Aurigemma GP, Devereux RB. Circulation; 2002 Jul 09; 106(2):227-32. PubMed ID: 12105163 [Abstract] [Full Text] [Related]
39. Normalization of cardiac structure and function after regression of cardiac hypertrophy. Habib GB, Mann DL, Zoghbi WA. Am Heart J; 1994 Aug 09; 128(2):333-43. PubMed ID: 8037101 [Abstract] [Full Text] [Related]
40. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. Galderisi M, D'Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G. J Hypertens; 2009 Oct 09; 27(10):2108-15. PubMed ID: 19564794 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]